Skip to main content
. 2014 Nov;196(21):3724–3734. doi: 10.1128/JB.01933-14

TABLE 3.

σA substitutions in bypass mutants

Independent enrichmenta Individualb Relative efficiencyc σA substitutiond
ALT 5 0.002 R297C
2 0.007 R316C
1 0.01 P287S
3 0.02 A171V
4 0.05 A171V
DET 1 0.0003
3 0.006 A171V
4 0.009
5 0.05 A171V
FLT 3 0.004 R355H
5 0.006 R355H
1 0.03 R316H
4 0.08 R355H
GAT 5 0.00008
4 0.02 R316H
2 0.06 R316H
3 0.08 A171V
1 0.09 R316H
ILT 3 0.0004
4 0.1 R316H
2 0.26 R316H
1 0.3 R316H
5 0.31 R316H
MAT 2 0.002
1 0.003
4 0.003 Y290C
3 0.01 R316H
5 0.02 A171V
MTT 4 0.008 R316H
3 0.03 A171T
2 0.06 A171V
1 0.07 R316H
5 0.07 R316H
NCT 1 0.001
3 0.02 A171V
5 0.02 A171V
2 0.07 A171V
4 0.07 A171V
NVT 2 0.003 V314A
4 0.02 A171V
5 0.02 A171V
3 0.07 V314A
1 0.1 R316H
NYT 5 0.00008
4 0.008 L363F
1 0.18 L363F
3 0.28 R316H
2 0.41 R316H
OHT 1 0.05 R355H
PRT 2 0.0009
1 0.003
3 0.04 R355H
4 0.1 R316H
5 0.1 R316H
6 0.2 R316H
SCT 5 0.08 R316H
4 0.1 R316H
2 0.13 R316H
TXT 2 0.06 R316H
5 0.1 R316H
4 0.11 R316H
WT 1 WT
ΔcomW 0.0001 WT
a

Name of enrichment series.

b

Tcr clone number.

c

Ratio of mutant transformation efficiency to that of the WT. The SD values of quadruplicate measurements were below 20%.

d

Boldface, mutation identified by WGS; −, isolate not sequenced.